UBC-Envision Group is the innovative scientific communications and technology arm of UBC, focused on the life science industry. We are an industry leader in medical publication planning, consultancy, execution, and technology. We work with clients and the medical publishing community to develop and execute evidence communication programs in a transparent and compliant manner. Our team members are sought-after industry leaders who are often consulted in publications policy, process, metrics, change management, and technology.
To match the needs of our clients, we are flexible in our approach to business – be it in team design and make up, payment models, offering whole solutions or key components, transfer of knowledge, or project timescales.
Publication and Scientific Solutions
— Practical, compliant publications policy development and
implementation.
— Comprehensive publications program strategy development,
management, and output.
— Publication audit preparation and mock audits.
— Objective assessment of processes and compliance for
publication plans.
— Content-driven scientific communications programs.
— Publications education via seminars (online or on-site).
Technology Solutions
We offer two technology platforms focused on critical areas in the development process that require the smart application of technology:
— Datavision™ – the industry leading publications planning tool,
utilized across the life science industry to help clients plan,
implement, and track their publications programs
— Visiontracker™ – a sophisticated software program that manages
external requests for funds such as investigator-sponsored
research, as well as medical education and charity grants.
Our Expert Team
Working with our clients we develop thoughtful medical publications plans that are implemented by a large, in-house team of medical writers who have advanced degrees and deep expertise in scientific publishing. Our experts are well versed in good publications practice guidelines, scientific journal and society guidelines, as well as legislative and regulatory mandates. Our dedicated client teams are experts in their chosen fields and comprise:
— Focused team leaders
— Expert consultants on publications and investigator-led trials
— Committed project managers
— Advanced degree professional medical writers
— Highly trained medical copyeditors
— Experienced graphic design and production team members
— Skilled in-house technology development and support personnel
— High-profile speakers and members of professional associations.
United BioSource Corporation (UBC)
UBC-Envision Group has grown dramatically since its inception. Our vision of bringing a robust scientific offering to our clients has driven our expansion and solution offerings. UBC-Envision Group has offices in both the United States and the United Kingdom and, importantly, our service line is dramatically expanded with our United BioSource Corporation (UBC) colleagues in interrelated disciplines all focused on affording greater market access.
UBC provides a comprehensive evidence-based solution portfolio to life science companies. We work across the development pipeline to identify evidence gaps, devise evidence generation opportunities, and assess and communicate those results by applying our expertise in science, strategy, technology, and execution. Our mission is built around the notion that products developed with a solid evidence base will deliver the greatest impact and success for all stakeholders, from industry to health care and insurance providers, governments, and patients. Our company has been deliberately designed to deliver on that premise.
Our business environment is in an intense state of change, where traditional product development and support models are quickly being exposed as insufficient. The increased demand for evidence and validation of product effectiveness coupled with ever increasing government demands and oversight has created a need for a different kind of company. Companies that focus on the development and commercialization of products that offer a robust value argument, well beyond the very basic efficacy and safety parameters, and a sustainable evidence model will have the greatest chance of success. That is the rationale behind UBC.
Please contact us today if you would like any further information about UBC-Envision Group
